Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding

H Barbhaiya, R McClain, A Ijzerman and SA Rivkees

Herman B. Wells Center for Pediatric Research, James Whitcomb Riley Hospital, Indiana University School of Medicine, Indianapolis 46202, USA.

To provide new insights into ligand/A1 adenosine receptor (A1 AR) interactions, site-directed mutagenesis was used to test the role of several residues in the first four transmembrane (TM) domains of the human A1 AR. Based on multiple sequence analysis of all known ARs, both acidic (glutamic acid and aspartic acid) and polar hydroxy (serine and threonine) amino acids were identified that could potentially play a role in binding adenosine. Glu16 (TM1), Asp55 (TM2), Ser93 and Ser94 (TM3), Ser135 (TM4), and Thr 141 (TM4) were identified in all ARs, and Ser6 and Ser23 (TM1) were identified in all A1 ARs. To test the role of these residues, each was individually mutated to alanine. When Ala6, Ala23, Ala50, Ala93, Ala135, and Ala141 constructs were tested, affinities for [3H]2-chloro-N6-cyclopentyladenosine (CCPA) and [3H]1,3- dipropyl-8-cyclopentylxanthine (DPCPX) were similar to those seen for the wild-type receptor. After conversion of Glu16 to Ala16, the affinity for [3H]CCPA and other agonists fell 10-100-fold, whereas the affinity for [3H]DPCPX and other antagonists was not affected. After conversion of Asp55 to Ala55, the affinity for [3H]CCPA and other agonists increased < or = 100-fold, whereas the affinity for [3H]DPCPX and other antagonists was not affected. Studies of the Ala55 construct also revealed that Asp55 is responsible for allosteric regulation of binding by sodium because the affinity for [3H]CCPA did not change over broad ranges of sodium concentrations. When Ser94 was converted to Ala94, A1 AR immunoreactivity was present on stable cell lines; however, functional binding sites could not be detected. When Ser94 was converted to Thr94, the affinity for some xanthine antagonists fell. These data show that Glu16 in TM1 and Asp55 in TM2 play important roles in agonist/A1 AR interactions and show that Asp55 is responsible for allosteric regulation of ligand/A1 AR binding by sodium. We also identify Ser94 as an important site for ligand binding.

Volume 50, Issue 6, pp. 1635-1642, 12/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure Physiol Rev, April 1, 2007; 87(2): 565 - 592. [Abstract] [Full Text] [PDF]

				M. W. Beukers, J. van Oppenraaij, P. P. W. van der Hoorn, C. C. Blad, H. d. Dulk, J. Brouwer, and A. P. IJzerman Random Mutagenesis of the Human Adenosine A2B Receptor Followed by Growth Selection in Yeast. Identification of Constitutively Active and Gain of Function Mutations Mol. Pharmacol., March 1, 2004; 65(3): 702 - 710. [Abstract] [Full Text] [PDF]

				Z.-G. Gao, S.-K. Kim, A. S. Gross, A. Chen, J. B. Blaustein, and K. A. Jacobson Identification of Essential Residues Involved in the Allosteric Modulation of the Human A3 Adenosine Receptor Mol. Pharmacol., May 1, 2003; 63(5): 1021 - 1031. [Abstract] [Full Text] [PDF]

				Z.-G. Gao, A. Chen, D. Barak, S.-K. Kim, C. E. Muller, and K. A. Jacobson Identification by Site-directed Mutagenesis of Residues Involved in Ligand Recognition and Activation of the Human A3 Adenosine Receptor J. Biol. Chem., May 17, 2002; 277(21): 19056 - 19063. [Abstract] [Full Text] [PDF]

				B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552. [Abstract] [Full Text] [PDF]

				K. A. Neve, M. G. Cumbay, K. R. Thompson, R. Yang, D. C. Buck, V. J. Watts, C. J. DuRand, and M. M. Teeter Modeling and Mutational Analysis of a Putative Sodium-Binding Pocket on the Dopamine D2 Receptor Mol. Pharmacol., August 1, 2001; 60(2): 373 - 381. [Abstract] [Full Text] [PDF]

				S. A. Rivkees, H. Barbhaiya, and A. P. IJzerman Identification of the Adenine Binding Site of the Human A1 Adenosine Receptor J. Biol. Chem., February 5, 1999; 274(6): 3617 - 3621. [Abstract] [Full Text] [PDF]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]